IO Biotech, Inc. (IOBT)
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
Address
OLE MAALOES VEH 3
COPENHAGEN, G7 2200
Founded
2014
Number of Employees
68
Website
http://www.iobiotech.com
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)